Beth Seidenberg and Sean Harper, Westlake Village
December 15, 2020 07:37 AM ESTUpdated April 13, 11:35 AM
Financing

Sean Harp­er and Beth Sei­den­berg add $500M to their new VC, bet­ting on the LA biotech ecosys­tem

Jason Mast

Editor

When Ar­se­nal Bio launched last year, the head­line name was Nap­ster bil­lion­aire Sean Park­er, who, af­ter fund­ing an im­munother­a­py in­sti­tute, de­cid­ed to back a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Viking CEO on ‘shock­ing’ mar­ket re­ac­tion to oral obe­si­ty da­ta, prepar­ing for Phase 3

Sana nar­rows fo­cus again to ze­ro in on di­a­betes and au­toim­mune dis­ease

Ver­tex makes mon­ey from sick­le cell ther­a­py Cas­gevy

The elec­tion is Tues­day. What’s at stake for the phar­ma in­dus­try?

Is there room for MASH drugs in a GLP-1 world?

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times